Predictive accuracy of scoring models for rehospitalisation due to ADHF during a three-year follow-up period.

<p>Predictive accuracy of scoring models for rehospitalisation due to ADHF during a three-year follow-up period.</p

Baseline characteristics of patients and medical therapy upon hospital admission.

<p>*Recurrent MI, stroke, major bleed, CHF/shock, arrhythmia, renal failure;</p><p>MI—myocardial infarction, ACEI—angiotensin-converting enzyme inhibitor, ARB—angiotensin II receptor blockers, PCI—percutaneous coronary intervention, CABG—coronary artery bypass grafting, TIA—transient ischaemic attack, AHF—acute heart failure.</p><p>Baseline characteristics of patients and medical therapy upon hospital admission.</p

Risk-scoring models and their components.

<p>*Recurrent MI, stroke, major bleed, CHF/shock, arrhythmia, renal failure.</p><p>BP—blood pressure, LBBB—left bundle branch block; PCI—percutaneous coronary intervention.</p><p>Risk-scoring models and their components.</p

Predictive accuracy of scoring models for mortality during a three-year follow-up period.

<p>Predictive accuracy of scoring models for mortality during a three-year follow-up period.</p

Landmark analyses of mortality after STEMI.

<p>Landmark analyses of mortality after STEMI.</p

Characteristics of laboratory tests and invasive procedures.

<p>IRA—infarct-related artery, LAD—left anterior descending artery, CABG—coronary artery bypass graft, RCA—right coronary artery, RPLD—ramus posterolateral dexter, RIVP—ramus interventricularis posterior, RCx—ramus circumflexus, RMS—ramus marginalis sinister, RIM—ramus intermedius, RD—ramus diagonalis, BNP—brain natriuretic peptide, LVEF—left ventricular ejection fraction.</p><p>Characteristics of laboratory tests and invasive procedures.</p

Cumulative occurrence of mortality and repeat hospitalisation for ADHF over time.

<p>Cumulative occurrence of mortality and repeat hospitalisation for ADHF over time.</p

Distributions of RA intimal layer volume in baseline and follow-up measurements.

<p>Distributions of RA intimal layer volume in baseline and follow-up measurements.</p

Change in the volume of intima layer of the arterial wall in individual patients (mm³).

<p>Change in the volume of intima layer of the arterial wall in individual patients (mm³).</p

Comparison of baseline characteristics in patients with decreased and increased volume of intima (N = 96).

<p>Comparison of baseline characteristics in patients with decreased and increased volume of intima (N = 96).</p